scholarly article | Q13442814 |
P50 | author | Silvano Ferrini | Q39791275 |
Luca Longo | Q54265560 | ||
Marco Chierici | Q55298377 | ||
Alberto Garaventa | Q57072396 | ||
Massimo Conte | Q57307345 | ||
Michela Croce | Q84277400 | ||
P2093 | author name string | Gian Paolo Tonini | |
Cesare Furlanello | |||
Marilena De Mariano | |||
Roberta Gallesio | |||
P2860 | cites work | Oncogenic mutations of ALK kinase in neuroblastoma | Q39928776 |
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma | Q39928780 | ||
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window. | Q40165924 | ||
ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma. | Q40250682 | ||
Germline PHOX2B mutation in hereditary neuroblastoma | Q42586619 | ||
Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma. | Q43225298 | ||
UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker. | Q53352914 | ||
Neuroblastoma | Q54265665 | ||
Recent advances in neuroblastoma | Q56637924 | ||
Genetic Predisposition to Familial Neuroblastoma: Identification of Two Novel Genomic Regions at 2p and 12p | Q58328226 | ||
PHOX2B mutations and genetic predisposition to neuroblastoma | Q58328232 | ||
Oligogenic inheritance in neuroblastoma | Q60035816 | ||
Targeted capture and massively parallel sequencing of 12 human exomes | Q24615381 | ||
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma | Q24645352 | ||
N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers | Q24648283 | ||
Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 | ||
Identification of ALK as a major familial neuroblastoma predisposition gene | Q24655923 | ||
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma | Q24656264 | ||
Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family | Q26864268 | ||
Activating mutations in ALK provide a therapeutic target in neuroblastoma | Q27851452 | ||
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. | Q27852211 | ||
A method and server for predicting damaging missense mutations | Q27860835 | ||
The Sequence Alignment/Map format and SAMtools | Q27860966 | ||
The genomic landscapes of human breast and colorectal cancers | Q27861078 | ||
Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14 | Q28200937 | ||
The epidemiology of neuroblastoma: a review | Q28307370 | ||
The lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 is involved in O-glycosylation of a polypeptide with multiple acceptor sites | Q28571370 | ||
An exploratory study of ambient air toxics exposure in pregnancy and the risk of neuroblastoma in offspring | Q28657377 | ||
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma | Q28943271 | ||
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm | Q29547194 | ||
N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry | Q33548177 | ||
Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci. | Q33855434 | ||
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma | Q33909753 | ||
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. | Q34006269 | ||
VarScan: variant detection in massively parallel sequencing of individual and pooled samples | Q34018143 | ||
Integrative genomics identifies LMO1 as a neuroblastoma oncogene | Q34152903 | ||
Neuroblastoma: biological insights into a clinical enigma | Q34180699 | ||
A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma | Q34365193 | ||
Death to the bad guys: targeting cancer via Apo2L/TRAIL. | Q36042489 | ||
The potential of death receptor 4- and 5-directed therapies in the treatment of lung cancer | Q36903123 | ||
The genetic landscape of high-risk neuroblastoma | Q36929803 | ||
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers | Q37293142 | ||
New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK. | Q38130615 | ||
GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7. | Q38981475 | ||
GALNT9 gene expression is a prognostic marker in neuroblastoma patients | Q39247881 | ||
Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis | Q39730101 | ||
P433 | issue | 28 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neuroblastoma | Q938205 |
P304 | page(s) | 26335-26346 | |
P577 | publication date | 2015-09-01 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Identification of GALNT14 as a novel neuroblastoma predisposition gene | |
P478 | volume | 6 |
Q30252766 | A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes. |
Q47839039 | Cell death-based treatment of neuroblastoma |
Q52793910 | Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. |
Q94595614 | Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer |
Q33710048 | GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma |
Q42232294 | GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma. |
Q37519157 | GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment |
Q89879441 | GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers |
Q39273903 | Genetic susceptibility to neuroblastoma |
Q52339753 | Genetic susceptibility to neuroblastoma: current knowledge and future directions. |
Q98177546 | Genomic Analysis Identifies New Loci Associated With Motor Complications in Parkinson's Disease |
Q52667529 | Investigating piwi-interacting RNA regulome in human neuroblastoma. |
Q38702196 | Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors. |
Q57493791 | Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and Genotype |
Q64264952 | Rare copy number variants contribute pathogenic alleles in patients with intestinal malrotation |
Q39412574 | Retinoblastoma and Neuroblastoma Predisposition and Surveillance |
Q39208675 | The MYCN Protein in Health and Disease |
Search more.